// Marc Aubry 2, 3, * , Marie de Tayrac 1, 2, 4, * , Amandine Etcheverry 1, 2, 4 , Anne Clavreul 6 , Stéphan Saikali 5, 8 , Philippe Menei 6, 7 , Jean Mosser 1, 2, 3, 4 1 CNRS, UMR 6290, Institut de Génétique et Développement de Rennes (IGdR), Rennes F-35043, France 2 Université Rennes1, UEB, UMS 3480 Biosit, Faculté de Médecine, Rennes F-35043, France 3 Plate-forme Génomique Santé Biosit, Université Rennes1, Rennes F-35043, France 4 CHU Rennes, Service de Génétique Moléculaire et Génomique, Rennes F-35033, France 5 CHU Rennes, Service d’Anatomie et Cytologie Pathologiques, Rennes F-35033, France 6 INSERM UMR-1066, Micro et Nano-Médecines Biomimétiques (MINT), Angers F-49933, France 7 CHU Angers, Département de Neurochirurgie, Angers F-49933, France 8 Service d’Anatomie Pathologique, Hôpital de l’Enfant-Jésus, Québec, Canada * These authors have contributed equally to this work Correspondence to: Marc Aubry, e-mail: marc.aubry@univ-rennes1.fr Keywords: glioblastoma, intratumor heterogeneity, integrative functional genomics, invasion Received: January 14, 2015 Accepted: April 06, 2015 Published: April 16, 2015 ABSTRACT Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite aggressive therapies. One of the most challenging problems in therapy of GB is its extremely complex and heterogeneous molecular biology. To explore this heterogeneity, we performed a genome-wide integrative screening of three molecular levels: genome, transcriptome, and methylome. We analyzed tumor biopsies obtained by neuro-navigation in four distinct areas for 10 GB patients (necrotic zone, tumor zone, interface, and peripheral brain zone). We classified samples and deciphered a key genes signature of intratumor heterogeneity by Principal Component Analysis and Weighted Gene Co-expression Network Analysis. At the genome level, we identified common GB copy number alterations and but a strong interindividual molecular heterogeneity. Transcriptome analysis highlighted a pronounced intratumor architecture reflecting the surgical sampling plan of the study and identified gene modules associated with hallmarks of cancer. We provide a signature of key cancer-heterogeneity genes highly associated with the intratumor spatial gradient and show that it is enriched in genes with correlation between methylation and expression levels. Our study confirms that GBs are molecularly highly diverse and that a single tumor can harbor different transcriptional GB subtypes depending on its spatial architecture.
No takes yet. Share an insight, caveat, or question.
Aubry et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: